Search
                    Venous Thromboembolism Clinical Trials
A listing of 18  Venous Thromboembolism  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 12 of 18
        
                There are currently 18 active clinical trials seeking participants for Venous Thromboembolism research studies. The states with the highest number of trials for Venous Thromboembolism participants are Ontario, Florida, California and Texas.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Glioblastoma Remote Monitoring and Care - Research Protocol
                                
            
            
        Recruiting
                            
            
                The purpose of this research is to learn more about how what the Apple watch measures, in terms of walking data, heart rate, breathing rate, and sleep habits, relates to how participants feel. During the course of the treatment, the symptoms participants experience change, and whether the Apple watch can detect these changes. Ultimately, this knowledge is being used to design proactive tools and signatures that can predict complications or symptom changes before they happen.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/08/2025
            
            Locations: Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio         
        
        
            Conditions: Glioblastoma, Venous Thromboembolism, Seizures
        
            
        
    
                
                                    A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)
                                
            
            
        Recruiting
                            
            
                This study is researching 2 different experimental drugs called REGN9933 and REGN7508 (called "study drugs"). The study is focused on adults undergoing a placement of a catheter in the vein, also called a 'PICC line'.
The aim of the study is to see how effective the study drug is at preventing venous thromboembolism (VTE) and other related disease after catheter placement.
The study is looking at several other research questions, including:
* What side effects may happen from taking the study...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/13/2025
            
            Locations: Sylvester Comprehensive Cancer Center, Miami, Florida  +18 locations         
        
        
            Conditions: Venous Thromboembolism
        
            
        
    
                
                                    DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
                                
            
            
        Recruiting
                            
            
                This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clin...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/06/2025
            
            Locations: Honor Health, Scottsdale, Arizona  +58 locations         
        
        
            Conditions: Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
        
            
        
    
                
                                    The Protrieve PROTECTOR Study
                                
            
            
        Recruiting
                            
            
                The Protrieve PROTECTOR Study is a prospective, single-arm, multicenter study of the Protrieve Sheath.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/04/2025
            
            Locations: Hoag Hospital, Newport Beach, California  +14 locations         
        
        
            Conditions: Venous Thromboembolism, Deep Venous Thrombosis
        
            
        
    
                
                                    PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
                                
            
            
        Recruiting
                            
            
                The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.             
        
        
    Gender:
                FEMALE
            Ages:
                Between 18 years and 60 years
            Trial Updated:
                07/29/2025
            
            Locations: Duke University Hospital, Durham, North Carolina  +9 locations         
        
        
            Conditions: Pregnancy Related, Venous Thromboembolism
        
            
        
    
                
                                    Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
                                
            
            
        Recruiting
                            
            
                While blood clots after major cancer surgery are common and harmful to patients, the medications to decrease blood clot risk are seldom used after patients leave the hospital despite the recommendation of multiple professional medical societies. The reason why these medications are seldom prescribed is not well understood. The main questions this study aims to answer are:
* Does surgeon education paired with an electronic medical record based decision support tool improve the guideline concorda...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/28/2025
            
            Locations: Medical University of South Carolina, Charleston, South Carolina         
        
        
            Conditions: Venous Thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis, Cancer, Surgery
        
            
        
    
                
                                    CLEANer Aspiration for Pulmonary Embolism
                                
            
            
        Recruiting
                            
            
                To evaluate the safety and efficacy of the Cleaner™ Pro Thrombectomy System for aspiration thrombectomy in patients with acute pulmonary embolism (PE).             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/02/2025
            
            Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado  +10 locations         
        
        
            Conditions: Pulmonary Embolism, Acute Pulmonary Embolism, Cardiovascular Diseases, Venous Thromboembolism
        
            
        
    
                
                                    Supplemental Oxygen in Pulmonary Embolism (SO-PE)
                                
            
            
        Recruiting
                            
            
                A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE).
Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure, and that this process is metabolically driven.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/12/2025
            
            Locations: Massachusetts General Hospital, Boston, Massachusetts         
        
        
            Conditions: Pulmonary Embolism, Venous Thromboembolism, Metabolomics, Oxygen Inhalation Therapy
        
            
        
    
                
                                    Evaluation of the SCALED (SCaling AcceptabLE cDs)
                                
            
            
        Recruiting
                            
            
                This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previously implementing this guideline. The Our overall goal is to successfully scale, evaluate, and maintain an interoperable TBI CDS across 7 total institutions.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                03/21/2025
            
            Locations: University of Minnesota, Minneapolis, Minnesota         
        
        
            Conditions: Traumatic Brain Injury, Venous Thromboembolism
        
            
        
    
                
                                    Computerized Registry of Patients With Venous Thromboembolism (RIETE)
                                
            
            
        Recruiting
                            
            
                The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism.
The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, particularly in those subgroups of patients who are usually not recruited in randomized clinical trials (...  Read More             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                03/10/2025
            
            Locations: Yale University School of Medicine, New Haven, Connecticut  +249 locations         
        
        
            Conditions: Venous Thromboembolism
        
            
        
    
                
                                    A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
                                
            
            
        Recruiting
                            
            
                This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with gastrointestinal (GI)/genitourinary (GU) cancer associated VTE (Magnolia)             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/18/2024
            
            Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado  +184 locations         
        
        
            Conditions: Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism
        
            
        
    
                
                                    A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
                                
            
            
        Recruiting
                            
            
                This is a Phase 3,multicenter, randomized, open-label, blinded endpoint evaluation study comparing the effect of abelacimab relative to apixaban on venous thromboembolism (VTE) recurrence and bleeding in patients with cancer associated VTE (ASTER)             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                12/18/2024
            
            Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado  +218 locations         
        
        
            Conditions: Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism
        
            
        
    1 - 12 of 18
            